CME
Interpretation and Application of RWE to Inform Shared Decision-Making in Metastatic HR+ Breast Cancer
February 10, 2023
Guest: Hope S. Rugo, MD, FASCO Guest: Adam M. Brufsky, MD, PhD The introduction of cyclin-dependent kinase (CDK) 4/6 inhibitors has drastically changed the treatment landscape of hormone receptor-positive/human epidermal growth factor recept
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!